News

Inequitable Conduct Accusations Still Powerful Pharma Patent Litigation Tool Post-Therasense

Bloomberg Law
July 22, 2019

"In patent litigation, the accusation of 'inequitable conduct' – 'fraud-like' behavior in the Patent Office to obtain a patent – if proven, makes patents unenforceable. The accusation, however, is controversial in the otherwise cerebral world of patent law. The Federal Circuit has described such accusations as a 'plague' upon the system where honorable patent attorneys and scientists have their reputations sullied. Others contend that the lure of obtaining valuable patents through deceit must be deterred."

Read the article

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.